141 related articles for article (PubMed ID: 20148990)
1. Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: development of a novel pre-biopsy nomogram.
Ohigashi T; Kanao K; Mizuno R; Kikuchi E; Nakashima J; Oya M
Int J Urol; 2010 Mar; 17(3):274-80. PubMed ID: 20148990
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment to Predicting the probability significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: development of a novel pre-biopsy nomogram.
Yamamoto S
Int J Urol; 2010 Mar; 17(3):280. PubMed ID: 20409219
[No Abstract] [Full Text] [Related]
3. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
4. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
Lee A; Lim J; Gao X; Liu L; Chia SJ
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
[TBL] [Abstract][Full Text] [Related]
5. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy.
Kim TH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
Scand J Urol; 2017 Feb; 51(1):27-32. PubMed ID: 28168924
[TBL] [Abstract][Full Text] [Related]
6. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
[TBL] [Abstract][Full Text] [Related]
8. A new nomogram to predict pathologic outcome following radical prostatectomy.
Crippa A; Srougi M; Dall'Oglio MF; Antunes AA; Leite KR; Nesrallah LJ; Ortiz V
Int Braz J Urol; 2006; 32(2):155-64. PubMed ID: 16650292
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
[TBL] [Abstract][Full Text] [Related]
10. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ
Int J Urol; 2010 Nov; 17(11):914-22. PubMed ID: 20880361
[TBL] [Abstract][Full Text] [Related]
11. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens.
Satake N; Ohori M; Yu C; Kattan MW; Ohno Y; Miyakawa A; Hatano T; Tachibana M
Int J Urol; 2010 Mar; 17(3):267-72. PubMed ID: 20132361
[TBL] [Abstract][Full Text] [Related]
12. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
[TBL] [Abstract][Full Text] [Related]
14. Preoperative nomograms for predicting extracapsular extension in Korean men with localized prostate cancer: a multi-institutional clinicopathologic study.
Chung JS; Choi HY; Song HR; Byun SS; Seo Si; Song C; Cho JS; Lee SE; Ahn H; Lee ES; Kim WJ; Chung MK; Jung TY; Yu HS; Choi YD
J Korean Med Sci; 2010 Oct; 25(10):1443-8. PubMed ID: 20890424
[TBL] [Abstract][Full Text] [Related]
15. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
Sun J; Zhang Z; OuYang J
Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
[TBL] [Abstract][Full Text] [Related]
16. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
[TBL] [Abstract][Full Text] [Related]
17. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.
Tang P; Chen H; Uhlman M; Lin YR; Deng XR; Wang B; Yang WJ; Xie KJ
Asian J Androl; 2013 Jan; 15(1):129-33. PubMed ID: 23291910
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
[TBL] [Abstract][Full Text] [Related]
19. External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
Tanaka A; Ohori M; Paul L; Yu C; Kattan MW; Ohno Y; Tachibana M
Jpn J Clin Oncol; 2013 Dec; 43(12):1255-60. PubMed ID: 24146147
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
